ALVR logo

AlloVir, Inc. Common Stock


ALVR: AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T-cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.


Show ALVR Financials

Consumer Interest
SEC Filings

Recent trades of ALVR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ALVR's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ALVR in WallStreetBets Daily Discussion


Recent insights relating to ALVR

CNBC Recommendations

Recent picks made for ALVR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALVR

Corporate Flights

Flights by private jets registered to ALVR